Abbott and new global consortium partnership address viral outbreaks caused by climate change

Abbott is joining the climate amplified disease and epidemics (climade) consortium, which will use data science to predict, track and control diseases that may be amplified by climate change a changing climate may increase the spread of both known and unknown viruses, particularly those transmitted by water or animals carrying diseases climade's initial work will start with disease surveillance in africa and expand to countries often impacted by infectious disease outbreaks caused by climate change abbott park, ill., april 20, 2023 /prnewswire/ -- abbott (nyse: abt) announced today that it is partnering with the climate amplified disease and epidemics (climade) consortium, a group of more than 100 global scientists in public health agencies, academia and industry focused on using data science technology and diagnostic testing to assess and potentially mitigate the impact climate change has on disease outbreaks.
ABT Ratings Summary
ABT Quant Ranking